KRTL BioTech

LSE's $27 billion Refinitiv takeover plan lifts its shares to record

LSE's $27 billion Refinitiv takeover plan lifts its shares to record

London Stock Exchange shares rose more than 14% to a record high on Monday after it said it was in talks to buy financial data firm Refinitiv, in a deal worth $27 billion including debt.